JUNG, SOONMD NPI 1528407392 Clinician
Anesthesiology · ALLENTOWN, PA
- OXYGEN OASIS HYPERBARIC WELLNESS CENTER, LLC — LANGHORNE, PA
- OXYGEN THERAPURITY, LLC — LANGHORNE, PA
- SE PAIN MANAGEMENT, LTD — ABINGTON, PA
- HOSPITAL OF UNIV OF PENNSYLVANIA · Hospital · CCN 390111
- JEFFERSON EINSTEIN MONTGOMERY HOSPITAL · Hospital · CCN 390329
- ST MARY MEDICAL CENTER · Hospital · CCN 390258
Group affiliation since 2019
Membership spans across every group on this clinician's 2019+ registry record, departed groups included. Membership spans only — no volume is attributed to any group here.
Provider overview · all codes · CY2024
The full analytics for this provider
PremiumThe full billed-volume analytics for this provider — its position among specialty peers, practice focus, and the payments behind it — computed from the same disclosed Medicare Part B data.
- Charge, service & beneficiary totals — the disclosed scale, all codes
- Practice profile — focus & reach — top codes by share of services
- Office vs. facility setting mix — place-of-service code split
- Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
- Peer positioning — code breadth — how many codes billed, vs peers
Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.
Notify me at launch → Or see a live example profile →Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Volume locked column | Beneficiary-episodes locked column | Avg charge locked column | Avg Medicare payment locked column |
|---|---|---|---|---|---|
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | premium | premium | premium | premium |
| J1010 | Injection, methylprednisolone acetate, 1 mg | premium | premium | premium | premium |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 96127 | Assessment of emotional or behavioral problems | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | premium | premium | premium | premium |
| 80307 | Testing for presence of drug, by chemistry analyzers | premium | premium | premium | premium |
| 62323 | Injection of substance into lower spine canal using imaging guidance | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | premium | premium | premium | premium |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | premium | premium | premium | premium |
| 77002 | Fluoroscopic guidance for needle placement | premium | premium | premium | premium |
| 20610 | Aspiration and/or injection of fluid from large joint | premium | premium | premium | premium |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | premium | premium | premium | premium |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | premium | premium | premium | premium |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | premium | premium | premium | premium |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | premium | premium | premium | premium |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | premium | premium | premium | premium |
| 20553 | Injection of trigger points, 3 or more muscles | premium | premium | premium | premium |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | premium | premium | premium | premium |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | premium | premium | premium | premium |
| J1040 | Injection, methylprednisolone acetate, 80 mg | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.